Details of the Drug

General Information of Drug (ID: DM6RTN3)

Drug Name
MIB-626
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Phase 1/2 [1]
Cross-matching ID
TTD ID
DN0A1J

References

1 ClinicalTrials.gov (NCT05040321) A Proof of Concept Trial of a Sirtuin-NAD Activator in Alzheimer's Disease. U.S.National Institutes of Health.